Pearl River Capital, LLC Halozyme Therapeutics, Inc. Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $238,143 - $307,960	6,376 New	6,376 $281,000
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $545,624 - $720,802	-14,048 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $555,036 - $722,769	14,048 New	14,048 $586,000
Q1 2019 May 02, 2019	SELL	$13.94 - $17.58 $5,645 - $7,119	-405 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$13.33 - $18.66 $5,398 - $7,557	405 New	405 $6,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.